Recursion Pharmaceuticals, Inc. (RXRX) News
Track canonical SquawkNews coverage tagged to RXRX, Recursion Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Cramer likes Vistra, Constellation Energy, Fastly after earnings
Jim Cramer said he likes Vistra and Constellation Energy on CNBC, called Fastly “back from the abyss,” and said Recursion, NextEra and Huntington Ingalls on the show.
EARNINGS | Aug 13, 2026, 12:00 PM UTC
L
RXRX - Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program - Click
RXRX - Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
EARNINGS | Aug 05, 2026, 10:30 AM UTC
L
RXRX Grants Inducement Awards
RXRX grants inducement awards
EQUITY | Jul 31, 2026, 08:30 PM UTC
L
RXRX - Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
RXRX - Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
EARNINGS | Jul 29, 2026, 12:30 PM UTC
L
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
2026-07-03 11:34:15 ET As the biotechnology landscape shifts toward personalized medicine and advanced computing, investors are weighing established leaders against emerging tech-driv
EQUITY | Jul 03, 2026, 03:34 PM UTC
H
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI
While corporate America is becoming more selective about using artificial intelligence as a rationale for acquisitions, Anthropic is making its biggest bet yet that AI will reshape scientific research. The AI startup on
MNA | Jul 01, 2026, 11:50 AM UTC